Association of aberrant expression of CD39 with the outcome of patients with cholangiocarcinoma. This is an ASCO Meeting Abstract from the ASCO Breakthrough: A Global Summit for Oncology Innovators.
Circulating tumor DNA as a prognostic biomarker to predict retroperitoneal histology in patients undergoing retroperitoneal lymph node dissection. AUC values of different ML algorithms on training and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results